在结直肠癌中,CPT1A调解了辐射敏感性
Zhenhui Chen1, Lu Yu2, Zhihao Zheng2
1Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
eLife
|November 28, 2024
概括
卡尼丁棕基转移酶1A (CPT1A) 在结肠直肠癌 (CRC) 中被下调,导致放射电阻. 恢复CPT1A通过调节活性氧物种 (ROS) 和DNA修复来增强辐射敏感性,为CRC提供了一个新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 放射治疗研究 放射治疗研究
背景情况:
- 结肠直肠癌 (CRC) 的发病率和死亡率在全球范围内不断上升.
- 辐射耐药性限制了晚期CRC放射治疗的有效性,导致复发和转移.
- 了解CRC电阻的分子基础对于改善治疗结果至关重要.
研究的目的:
- 调查卡尼丁棕基转移酶1A (CPT1A) 在CRC放射电阻中的作用.
- 阐明CPT1A影响放射敏感性的分子机制.
- 评估CPT1A作为一种潜在的生物标志物和治疗目标,以增强CRC放射治疗.
主要方法:
- 生物信息分析和瘤组织检查以评估CPT1A的表达.
- 在体外和体内实验中使用lentiviral载体 (过度表达和CRISPR/Cas9) 来操纵CPT1A水平.
- 转录基因测序,分子生物学试验和辐射暴露研究以探索机制.
- 评估反应性氧物种 (ROS) 清除和DNA损伤反应.
主要成果:
- 在CRC组织中,CPT1A显著下调,与新辅助放射治疗反应负相关.
- 过度表达CPT1A增强了辐射敏感性,而其下调则促进了放射电阻.
- CPT1A影响ROS水平和DNA损伤修复途径.
- 机械研究表明,CPT1A降低FOXM1-SOD1/SOD2/CAT轴的调节,减少ROS和增强辐射敏感性.
结论:
- 通过增强FOXM1介导的抗氧化反应,CPT1A下调有助于CRC中的放射电阻.
- 通过ROS调节和DNA修复,CPT1A充当放射敏感性的调解者.
- CPT1A代表了一个有前途的生物标志物来预测放射性敏感性,也是克服CRC中放射电阻的新型治疗标.
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


